Teva To Buy CoGenesys For USD 400 Mln In Biogenerics Push
Capital of the United Kingdom — Teva Pharmaceutical informated it’s purchasing CoGenesys, a privately-held biopharmaceutical, for USD 400 000 000 in cash. Teva expressed the business deal will help it get a conducting player in the biogenerics market.